Hunter Syndrome (MPS II)
Neurology·MeSH: Mucopolysaccharidosis II
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Hunter Syndrome (MPS II)?
There are 1 clinical trial targeting Hunter Syndrome (MPS II) tracked by BioSniper.
What is the prevalence of Hunter Syndrome (MPS II)?
The estimated prevalence of Hunter Syndrome (MPS II) is approximately 0.1 per 100,000 population.
Deep-dive into Hunter Syndrome (MPS II)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis